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Abstract
Background: Corticosteroid hormones regulate appraisal and consolidation of information via mineralocorticoid receptors
(MRs) and glucocorticoid receptors (GRs) respectively. How activation of these receptors modulates retrieval of fearful
information and the subsequent expression of fear is largely unknown. We tested here whether blockade of MRs or GRs
during retrieval also affects subsequent expression of fear memory.
Methodology/Principal Findings: Mice were trained in contextual or tone cue fear conditioning paradigms, by pairing mild
foot shocks with a particular context or tone respectively. Twenty-four hours after training, context-conditioned animals
were re-exposed to the context for 3 or 30 minutes (day 2); tone-conditioned animals were placed in a different context and
re-exposed to one or six tones. Twenty-four hours (day 3) and one month later, freezing behavior to the aversive context/
tone was scored again. MR or GR blockade was achieved by giving spironolactone or RU486 subcutaneously one hour
before retrieval on day 2. Spironolactone administered prior to brief context re-exposure reduced freezing behavior during
retrieval and 24 hours later, but not one month later. Administration of spironolactone without retrieval of the context or
immediately after retrieval on day 2 did not reduce freezing on day 3. Re-exposure to the context for 30 minutes on day 2
significantly reduced freezing on day 3 and one month later, but freezing was not further reduced by spironolactone.
Administration of spironolactone prior to tone-cue re-exposure on day 2 did not affect freezing behavior. Treatment with
RU486 prior to re-exposure did not affect context or tone-cue fear memories at any time point.
Conclusions/Significance: We conclude that MR blockade prior to retrieval strongly reduces the expression of contextual
fear, implying that MRs, rather than GRs, play an important role in retrieval of emotional information and subsequent fear
expression.
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Introduction
Memories for emotionally arousing and stressful events are
generally well retained [1]. If sufficiently stressful, these events
activate the Hypothalamus-Pituitary-Adrenal (HPA)-axis which
increases the release of corticosteroid hormones from the adrenal
glands [2]. Corticosteroid hormones readily cross the blood brain
barrier and bind to high affinity mineralocorticoid receptors (MRs)
and lower affinity glucocorticoid receptors (GRs) [3]. Upon
binding to their receptors, corticosteroid hormones regulate and
promote distinct phases of learning and memory processes. Several
studies have shown that post-training activation of GRs promotes
consolidation of fearful information [4,5,6,7,8]. Activation of MRs
is critical for the appraisal of stressful information and response
selection [7,9,10]. In addition, genetic deletion of forebrain MRs
hampers spatial learning [11] and pharmacological blockade of
MRs impairs contextual fear conditioning [8,11].
Surprisingly little is known about how corticosteroid hormones
and their receptors regulate the retrieval of fearful information.
While exposure to stressful experiences and elevated corticosteroid
hormones has been reported to suppress the retrieval of spatial
information [12,13], it remains to be investigated whether
activation of MRs and GRs by endogenously released corticoste-
roid hormones is involved in this process. Regulation of retrieval
and subsequent (re)consolidation by MRs and/or GRs might
potentially take place for at least two reasons. First, retrieval of
fearful information is a stressful event in itself and accompanied by
elevated corticosteroid hormone levels [14]. Second, retrieval and
re-activation of fearful events renders these memories labile and
protein synthesis is required after reactivation to re-consolidate the
memory trace [15]. Reconsolidation has been demonstrated in
various tasks and species [15,16,17], including humans [18,19].
The notion that stored memories can be turned into a labile state
has opened new avenues to reduce excessive fears more
permanently than the traditional extinction procedure. For
example, treatment with b-adrenergic receptor antagonists during
re-exposure has been reported to affect the subsequent expression
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corticosteroid hormones, via activation of MRs and GRs, are
potent regulators of fearful memories, we explored here whether
blocking MRs and GRs during retrieval of a fearful context or tone
regulates the subsequent expression of fearful memories. We
report that MRs but not GRs regulate retrieval of fearful
information.
Results
MR blockade prior to brief context re-exposure reduces
fear expression
During training animals displayed a progressive increase in
freezing behavior (repeated measures ANOVA, F3, 99=29.91,
P,0.01). Importantly, freezing behavior during training was
comparable for the groups that were later treated with vehicle or
the MR-antagonist spironolactone (F1, 33=0.27, P.0.05). Twenty
three hours later, animals received either spironolactone or vehicle
injection. One hour after drug administration, animals were re-
exposed to the same context as used during training and freezing
behavior was measured at that time (day 2) as well as 24 hours
(day 3) and one month later. In the first series of experiments we
tested the effect of spironolactone given prior to brief (3 minutes)
context re-exposure (Figure 1). Repeated measures ANOVA
showed a main effect of time in both vehicle (F2, 16=17.87,
P,0.01) and spironolactone treated animals (F2, 16=22.88,
P,0.01). Multiple mean comparisons with post hoc Bonfferoni test
revealed that both vehicle and spironolactone treated mice showed
significantly less freezing behavior on day 3 (P,0.01) and one
month later (P,0.05) respectively, when compared to day 2
(Figure 1B). Repeated measures ANOVA also revealed a main
effect of treatment (F1, 16=9.92, P,0.01). Post hoc test showed that
treatment with spironolactone reduced freezing behavior during
retrieval (Day 2, P,0.01) as well as 24 hours after the retrieval
trial (Day 3, P,0.05) when compared to vehicle treatment. No
significant treatment effect was found one month after retrieval
(P.0.05). These results indicate that spironolactone, when applied
before a brief retrieval of contextual information reduces the
expression of fear for at least one day.
In a second series of experiments spironolactone was applied
23 hours after training, but in the absence of re-exposure to the
context (Figure 2A, NT). Under these conditions, no main effect of
spironolactone treatment (Figure 2B, F1, 10=0.44, P.0.05) was
observed. This indicates that spironolactone is only effective in
reducing the expression of fear when the drug is present during
retrieval of information. This was confirmed by another set of
experiments where spironolactone was administered immediately
after retrieval (Figure 3). In the vehicle-treated animals, no
statistical difference in freezing scores was found over time (day 2,
day 3 and one month later), by repeated measures ANOVA
(within-group comparison). Nevertheless, a paired t-test revealed
that animals froze significantly less on day 3 when compared to
day 2 (P=0.001), which is in agreement with the data presented in
Figure 1, and confirms that brief retrieval of contextual
information results in less freezing. No between-group effects of
spironolactone on freezing behavior were found at any time point.
Overall, these experiments reveal that blocking mineralocorticoid
receptors reduces the expression of contextual fear for at least one
day, but only when these receptors are blocked before/during
retrieval.
Placing animals in the same context for 3 minutes is thought to
initiate reactivation and subsequent reconsolidation, whereas
placement in this context for 30 minutes supposedly promotes
extinction learning [22]. To specifically explore the effect of
spironolactone treatment on extinction of fear memories, a
separate batch of animals was exposed to the context for 30
minutes on day 2, i.e. 24 hours after training (Figure 4A). We
determined the freezing behavior during the first 3 minutes of the
30-minutes retrieval period and compared this with freezing
scored on day 3 and one month later. Repeated measures
ANOVA revealed a time effect in both vehicle (F2, 16=39.08,
P,0.01) and spironolactone treated mice (F2, 14=11.85, P,0.01).
Post hoc test showed (as expected) that compared to day 2, both
vehicle and spironolactone treated animals displayed significantly
less freezing on day 3 (P,0.01) though one month later only
vehicle treated animals showed a significant reduction in freezing
scores (P,0.01). A between group effect of spironolactone was also
found (F1, 15=10.26, P,0.01). On day 2, spironolactone treated
animals displayed less freezing during the first 3 minutes of the
retrieval period when compared to vehicle treatment (Figure 4B,
Day 2, P,0.05).
MR blockade prior to tone cue re-exposure has no effect
on fear expression
We next tested if spironolactone modifies the expression of fear
when the drug is administered prior to retrieval of tone-cue
memories. During training in context A, freezing behavior during
and immediately after the tone was comparable between the
groups that were later treated with vehicle or spironolactone (data
not shown). One day after training, both vehicle and spironolac-
tone treated mice displayed high levels of freezing in response to
one tone in context B (Figure 5B). Data analysis indicated a main
time effect in both vehicle (F2, 12=9.40, P,0.01) and spironolac-
tone treated mice (F2, 12=35.59, P,0.01). When compared to day
2, both groups showed significant less freezing behavior on day 3
(vehicle: P,0.05; spironolactone: P,0.01) though one month later
only spironolactone treated group showed less freezing (P,0.01),
No between group-effect of spironolactone treatment was found
(F1, 12=0.26, P.0.05).
Repeated exposure to six tones on day 2 significantly decreased
the freezing behavior over time during extinction training (repeated
measures ANOVA, F2, 24=66.32, P,0.01). Freezing behavior was
also scored one day (day 3) and one month later (Figure 6A). A
significant within-subject effect was found over time in both vehicle
(F2, 12=38.84, P,0.01) and spironolactone (F2, 12=27.98, P,0.01)
treated mice; when compared to freezing behavior during the first
tone on day 2, less freezing was scored both on day 3 (Figure 6B,
P,0.01) and one month later (P,0.01) in both groups. No
between-group effect of spironolactone was observed (F1, 12=4.71,
P.0.05).
GR blockade prior to context re-exposure has no effect
on subsequent fear expression
During training animals displayed a progressive increase in
freezing behavior (repeated measures ANOVA, F3, 81=31.61,
P,0.01). No difference was found between the groups that were
later treatedwith vehicleor theGR-antagonist RU486(F1, 26=1.42,
P.0.05). One hour after drug treatment on day 2, freezing behavior
to the training context was measured for 3 minutes and then
compared to that measured one day (day 3) or one month later.
Repeated measures ANOVA showed a main time effect in both
vehicle (Figure 7B, F2, 12=9.77, P,0.01) and RU486 (F2, 12=4.77,
P,0.05) treated animals. Post hoc test revealed that, when compared
to day 2, only vehicle treated animals displayed significantly less
freezing on day 3 (P,0.01). No significant differences were found in
spironolactone treated animals or one month later (P.0.05). Also no
between-group effect of RU486 was found (F1, 12=0.11, P.0.05).
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in retrieval of contextual fearful information and subsequent
expression of fear.
In a separate experiment animals were injected with RU486 or
vehicle 23 hours after training and subsequently placed animals
into the training context for 30 minutes; freezing behavior was
scored on day 2, day 3 and one month later. Repeated measures
ANOVA indicated a significant time effect in both vehicle
(Figure 8B, F2, 12=26.29, P,0.01) and RU486 (F2, 12=40.83,
P,0.01) treated mice. Post hoc test showed that compared to the
first 3 min re-exposure on day 2, both groups showed a significant
reduction in freezing behavior on day 3 (P,0.01) bu not (P.0.05).
No between group effects of RU486 were found (F1, 12=0.002,
P.0.05). These results suggest that GR activation is not critically
involved in the effect of 30-minute retrieval process of contextual
fear information and subsequent expression of fear behavior.
GR blockade prior to tone-cue re-exposure has no effect
on subsequent fear expression
We next tested if RU486 affects the expression of tone-cue fear
memorywhenadministered priorto retrieval. During training,freezing
behavior during and immediately after the tone was comparable
between the mice that were later treated with either vehicle or RU486
(data not shown). Twenty-three hours later, mice were treated with
Figure 1. MR blockade prior to brief context re-exposure reduces subsequent fear expression. A) Behavioral procedure for the
experiment. B) Freezing behavior in both vehicle and spironolactone treated mice decreased both on day 3 and one month later when compared to
day 2. Treating mice with spironolactone one hour before brief (3 minutes) retrieval (day 2) reduced freezing behavior compared to vehicle treated
mice, both during the retrieval session and one day later (day 3).
# and
## reflect P,0.05 and P,0.01 respectively when compared to day 2;
*and**reflect P,0.05 and P,0.01 respectively when compared to vehicle treated mice at the same time point (n=9 mice per group).
doi:10.1371/journal.pone.0026220.g001
Figure 2. MR blockade without context re-exposure has no effect on subsequent fear expression. A) Behavioral procedure for the
experiment. B) Spironolactone was injected 23 hours after training in the absence of re-exposure to the fearful context on day 2. No effect of
spironolactone on contextual memory retention was found twenty four hours (day 3) or one month later (n=6 mice per group).
doi:10.1371/journal.pone.0026220.g002
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Freezing behavior was scored on day 2, day 3 and one month later
respectively (Figure 9A). Repeated measures ANOVA revealed a
significant time effect in both vehicle (Figure 9B, F2, 10=6.13,P,0.05)
and RU486 (F2, 10=15.35, P,0.01) treated mice. Post hoc test revealed
that vehicle treated group displayed a significant decrease in freezing
behavior on day 3 compared to day 2 (P,0.05), while RU486 treated
mice showed reduced freezing behavior one month later (P,0.05). No
between group effect of RU486 treatment was found on tone-cue
freezing (F1, 10=0.07, P.0.05).
Repeated exposures to six tones on day 2 resulted in a
significant decrease in freezing behavior (repeated measures
Figure 3. MR blockade immediately after brief context re-exposure has no effect on subsequent fear expression. A) Behavioral
procedure for the experiment. B) Freezing behavior during brief retrieval was comparable between the two groups. Treating animals with
spironolactone immediately after brief re-exposure did not affect contextual memory retention on day 3 or one month after retrieval (n=6 mice per
group).
doi:10.1371/journal.pone.0026220.g003
Figure 4. MR blockade prior to prolonged context re-exposure has no effect on subsequent fear expression. A) Behavioral procedure
for the experiment. B) Freezing behavior decreased in both vehicle and spironolactone treated animals on day 3 and one month later only vehicle
treated group showed difference in freezing scores, when compared to the first 3 minute re-exposure to the context on day 2. No between-group
effect was found except for the first 3 minutes during prolonged retrieval on day 2.
## reflects P,0.01 when compared to day 2. * reflects P,0.05
when compared to vehicle treated group (n=8–9 mice per group).
doi:10.1371/journal.pone.0026220.g004
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scored one day (day 3) and one month later (Figure 10A). A main
time effect was found in both vehicle (F2, 10=12.87, P,0.01) and
RU486 treated groups (F2, 20=17.29, P,0.01). Compared to day
2, vehicle group displayed less freezing behavior both on day 3
(Figure 10B, P,0.05) and one month later (P,0.05), while a
reduction in freezing behavior was only seen in RU486 group one
month later (P,0.01). No between group effect of RU486
treatment was found (F1, 10=0.11, P.0.05).
Discussion
Corticosteroid hormones modulate distinct phases of learning
and memory via activation of mineralocorticoid receptors (MRs)
Figure 5. MR blockade prior to one tone re-exposure has no effect on subsequent fear expression. A) Behavioral procedure for the
experiment. B) Freezing behavior decreased in only vehicle treated group on day 3 and in both groups one month later when compared to day 2. No
significant spironolactone effect was found when compared to vehicle treated group.
# and
## reflect P,0.05 and P,0.01 respectively when
compared to freezing on day 2 (n=7 mice per group).
doi:10.1371/journal.pone.0026220.g005
Figure 6. MR blockade prior to six-tone re-exposure has no effect on subsequent fear expression. A) Behavioral procedure for the
experiment. B) Freezing behavior decreased in both vehicle and spironolactone treated groups on day 3 and one month later when compared to the
first tone exposure on day 2. No differences were found between vehicle and spironolactone treatment.
## reflects P,0.01 when compared to
freezing on day 2 (n=7 mice per group).
doi:10.1371/journal.pone.0026220.g006
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activation of MRs and GRs is also critical for retrieval and
subsequent expression of fear. This is particularly interesting since
retrieval of fearful events supposedly turns these memories into a
labile state [17,23,24], which allows a window for pharmacological
intervention. We found that blocking MRs reduces for at least one
day the expression of fear after brief re-exposure to the fearful
context, whereas extinction learning or tone-cue fear conditioning
remained unaffected. Blocking GRs did not affect retrieval of
information, extinction and subsequent expression of contextual
and tone-cue fearful memories.
The protocol that we used to modulate the expression of fear–
i.e. re-exposure on day 2 to the training context for 3 or 30
minutes-was previously described to examine reconsolidation and
extinction of fearful memories respectively, which are two
opposing processes that may be triggered by a similar memory
retrieval procedure [22,25]. These studies showed that brief
retrieval of previously acquired fear induces reconsolidation, while
prolonged re-exposure results in extinction. Our data show that
activation of MRs during brief re-exposure but not prolonged re-
exposure regulates the subsequent expression of fear. This could
suggest that activation of MRs regulates reconsolidation of
Figure 7. GR blockade prior to brief context re-exposure has no effect on subsequent fear expression. A) Behavioral procedure for the
experiment. B) Freezing behavior decreased in only vehicle treated mice on day 3 compared to day 2. Treating mice with RU486 or vehicle (on day 2)
resulted in comparable freezing behavior over time.
# reflects P,0.05 when compared to freezing on day 2 (n=7 mice per group).
doi:10.1371/journal.pone.0026220.g007
Figure 8. GR blockade prior to prolonged context re-exposure has no effect on subsequent fear expression. A) Behavioral procedure
for the experiment. B) Freezing behavior in both vehicle and RU486 treated groups decreased on day 3 but not one month later when compared to
the first 3 minute context re-exposure on day 2. No difference in freezing behavior was found between vehicle and RU486 treated groups.
## reflects
P,0.01 when compared to freezing on day 2 (n=7 mice per group).
doi:10.1371/journal.pone.0026220.g008
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was really reconsolidated or subject to weak extinction by brief re-
exposure on day 2. We cannot exclude that MR blockade
transiently facilitates a weak form of extinction learning as a
significant spironolactone x re-exposure interaction effect was
observed during and 24 hours after the manipulation. Inducing
extinction learning with a stronger paradigm, i.e. by re-exposing
the mice to the adverse context for 30 minutes, did not result in
significant effects of spironolactone on freezing.
Our results demonstrate that MRs are critical duringthe retrieval
of contextual emotional information for the subsequent expression
of fear behavior, lasting at least one day but less than one month.
Mineralocorticoid receptors (MRs) have been implicated in
appraisal of novel and stressful events and response selection
[7,10]. If blocking MRs prior to retrieval affects response selection,
we would predict only a temporary reduction of fear expression
duringthe retrieval session, but a return of fear at the long-term.On
the other hand, if blocking MRs upon retrieval affects reappraisal of
theevent,amore permanentfearreductionwouldbeexpected.Our
current findings that spironolactone when administered prior to
retrieval of information reduces freezing behavior during re-
exposure as well as one day later (in the absence of the drug) but
not one month later suggests that MRs are involved in response
selection rather than re-appraisal of the fearful situation.
By blocking MRs, the relative contribution of GRs in behavioral
effects might be increased as blocking MRs could have impaired
Figure 9. GR blockade prior to one tone re-exposure has no effect on subsequent fear expression. A) Behavioral procedure for the
experiment. B) Freezing behavior in vehicle treated mice decreased on day 3 compared to day 2. Treatment with RU486 resulted in less freezing one
month later compared to day 2. No significant RU486 effect was found.
# reflects P,0.05 when compared to day 2 (n=6 mice per group).
doi:10.1371/journal.pone.0026220.g009
Figure 10. GR blockade prior to six-tone re-exposure has no effect on subsequent fear expression. A) Behavioral procedure for the
experiment. B) Freezing behavior in vehicle treated mice decreased both on day 3 and one month later when compared to the first tone exposure on
day 2. RU486 treated mice displayed reduced freezing one month later. No difference in freezing behavior was found between vehicle and RU486
treated animals.
#and
## reflect P,0.05 and P,0.01 respectively when compared to day 2 (n=6 mice per group).
doi:10.1371/journal.pone.0026220.g010
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axis activity, leading to increased secretion of corticosterone [26].
This is relevant, since elevated corticosteroid levels have been
reported to reduce retrieval of information and to promote the
extinction of irrelevant information via GR activation [27,28,29].
The presumably stronger GR activation seems unlikely to explain
the current findings, since 1) the effect of spironolactone observed
here is not restricted to the retrieval process only, as it lasts at least
till the next day; 2) spironolactone did not affect fear memory
when given after re-exposure; and 3) RU 486 treatment at the time
of retrieval did not affect any aspect of subsequent fear expression
(see also below). Therefore, the effects of spironolactone are most
likely the direct consequence of interfering with MR-mediated
processes. This may involve direct modulation of relevant
substrates for learning and memory such as plasticity at excitatory
synapses [30]. More specifically, corticosteroid hormones increase
hippocampal excitatory synaptic transmission via MRs [31,32]
and facilitate synaptic potentiation of these synapses via rapid non-
genomic actions [33].
While administration of spironolactone prior to retrieval
reduced the expression of contextual fear memory, tone-cue
memory remained unaffected. This also strongly argues against a
non-specific role of the drug in reducing fear expression. The
differential effectiveness of spironolactone in context versus tone-
cued memories could be explained by the MR distribution in areas
playing a major role in these two types of memories, that is, the
hippocampus and basolateral amygdala respectively. MRs are
highly expressed in all hippocampal fields, whereas MR expression
is much lower in the basolateral amygdala [2,3]. Also, the efficacy
of MRs to modulate synaptic transmission is different in amygdala
[34] compared to the hippocampus [32].
Several studies have shown that post-training application of GR
agonists promote (fearful) memory consolidation [5,35], while GR
antagonists suppress memory consolidation [7,8,10]. Our current
results show that blocking GRs - at a dosage that is effective in
hampering the consolidation of contextual fear – neither affected
the retrieval of fearful information nor regulated the subsequent
expression of fear. This may imply that GRs are critically involved
in promoting the storage of fearful information, while they play a
minor role in regulating already consolidated fearful information,
even when these memories are labile. Nevertheless, a recent study
described that post-retrieval application of RU486 (at a higher
dosage than used in our current study) was effective in impairing
memory reconsolidation in an inhibitory avoidance paradigm
[36]. This may indicate that GRs, under particular but not all
experimental conditions are able to regulate reconsolidation of
memory.
In conclusion, our results demonstrate that blocking MRs, but
not GRs, prior to retrieval of contextual fearful information




Male C57/BL6 mice (6–8 weeks old, Harlan, The Netherlands)
were housed (2 mice per cage) for at least one week after arrival. All
animals were kept on a light/dark cycle of 12 h (lights on at 8 a.m.;
humidity 55%615; room temperature kept at 22 uC 62) and food
and water were given without restriction. The experiments
(training, memory retrieval and testing) were performed between
8:30–11:30 a.m. and approved by the local Animal Ethics
Committee of the University of Amsterdam (DED212). All efforts
were made to minimize suffering of the animals.
Drugs and treatments
The mineralocorticoid receptor antagonist spironolactone
(Splac, Sigma, 50 mg/kg), glucocorticoid receptor antagonist
RU486 (Sigma, 10 mg/kg) or vehicle (Veh, propylene glycol)
was injected subcutaneously one hour before the retrieval of
contextual or tone-cued information (i.e. twenty three hours after
training) or immediately after retrieval. The dosage and drug
delivery route were chosen based on previous studies in which MR
mediated effects were effectively blocked by the administration of
MR antagonist [6,37,38] with little effect on spontaneous behavior
[39,40]. Similarly, GR-mediated effects could be prevented
sufficiently with the current administration method, as document-
ed previously [6].
Contextual Fear Conditioning
Animals were trained in a fear conditioning chamber (Context
A, W6L6H: 30 cm624 cm626 cm) that contained a grid floor
with 37 stainless steel rods and was connected to a shock generator
and sound generator (Med-Farm LION-ELD) developed in-house.
During training, one animal at one time was placed into context A.
After three minutes of free exploration, three foot shocks (2
seconds, 0.4 mA) were delivered with an interval of 90 seconds.
Sixty seconds after the end of the last foot shock, the mouse was
placed back into its home cage. Freezing behavior, defined as no
body movements except those related to respiration, was
determined every 2 seconds throughout the experiment [8,41].
Twenty three hours later on day 2, mice were injected
subcutaneously with either spironolactone, RU486 or vehicle
and returned to their homecages. One hour later one animal at a
time was placed in context A for either 3 or 30 minutes without
receiving any foot shock, presumably initiating reconsolidation
and extinction respectively based on previous studies [15,22,42].
Freezing behavior was scored throughout these periods. Twenty
four hours (day 3, i.e. 48 hours after training) and one month later
one animal at a time was placed in context A for 3 minutes without
receiving foot shock and freezing behavior was scored.
In separate control experiments, animals received the injection
with spironolactone or vehicle one day after training without or
immediately after the retrieval of contextual information. Freezing
behavior was monitored on day 2, day 3 and one month later.
Tone-cued Fear Conditioning
All animals were handled for three days before the start of the
experiments and placed for 20 minutes/day in context B which
has the same size as context A, but different contextual
background (odor, texture and color). During training, one mouse
at a time was placed into context A. After three minutes of free
exploration, the mouse was exposed to a tone (100 dB, 2.8 kHz)
that lasted for 30 seconds and co-terminated with a mild foot shock
(2 seconds, 0.4 mA) [8]. Thirty seconds later, the animal was
placed back in its homecage. Twenty three hours later (day 2),
mice were injected subcutaneously with spironolactone, RU486 or
vehicle and returned to the homecages. One hour later, one mouse
at a time was placed in context B. After 3 minutes of free
exploration, the animal was exposed to one tone for 30 seconds
(presumably initiating reconsolidation) or to 6 tones repetitively
with an inter-tone interval of 3 minutes (presumably initiating
extinction) without exposure to any foot shock. Thirty seconds
after the last tone, the mouse was returned to its homecage.
Freezing behavior was scored throughout the experiment. Twenty
four hours later (day 3, i.e. 48 hours after training) as well as one
month later, tone-cue memory was examined again by exposing
the mice to one tone in context B.
Mineralocorticoid Receptors and Memory Retrieval
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Freezing behavior is expressed as percentage of freezing time
versus total testing time. All results are presented as mean 6 SEM.
Freezing behavior was scored at 24 hours (Day 2), 48 hours (Day
3) and also one month after training. Freezing behavior was
therefore analyzed with repeated measures ANOVA (in SPSS 9.0),
with time as a repeated measure and drug treatment as between-
subject factor. Significant within-subject (time) effects and
between-subject (treatment) effects were followed up using
multiple mean comparions with Bonfferoni post hoc test. P values
smaller than 0.05 were considered to be significantly different.
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